Healthcare resource utilization in patients treated with empagliflozin in East Asia

Healthcare resource utilization in patients treated with empagliflozin in East Asia

ABSTRACT Aims/Introduction We investigated the utilization of healthcare resources in patients with type 2 diabetes treated with empagliflozin, a sodium‐glucose co‐transporter‐2 (SGLT2) inhibitor, versus dipeptidyl peptidase‐4 (DPP‐4) inhibitors in clinical practice in Japan, South Korea, and Taiwan...

Full description

Bibliographic Details
Main Authors: Wayne H‐H Sheu, Yutaka Seino, Elise Chia‐Hui Tan, Daisuke Yabe, Kyoung Hwa Ha, Masaomi Nangaku, Wook‐Jin Chung, Koichi Node, Atsutaka Yasui, Wei‐Yu Lei, Sunwoo Lee, Anastasia Ustyugova, Riho Klement, Anouk Deruaz‐Luyet, Moe H Kyaw, Dae Jung Kim, the EMPRISE East Asia study group
Format: Article
Language:English
Published: Wiley 2022-05-01
Series:Journal of Diabetes Investigation
Subjects:
Asia
Health resources
Sodium‐glucose co‐transporter 2 inhibitors
Online Access:https://doi.org/10.1111/jdi.13728

Internet

https://doi.org/10.1111/jdi.13728

Similar Items